Facebook Values WhatsApp Like Miracle Drug: Real M&A

Facebook Inc.’s $19 billion purchase of WhatsApp Inc. is valuing the text-messaging service at a multiple investors currently only bestow on companies developing life-saving drugs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.